A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary Fibrosis
Clinical trial NCT03949530 · TERMINATED
Trial details
- NCT number
- NCT03949530
- Sponsor
- Indalo Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-16
- Primary completion
- 2020-03-29
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.